Clinical Trial Update: Study of QLS1410 in the Treatment of Primary Aldosteronism. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for QLS1410 in primary aldosteronism; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• QLS1410

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Primary Aldosteronism | Phase 2 | Status: NOT_YET_RECRUITING